MedPath

Effects of Low Protein Diet in Preventing the Progression of Chronic Kidney Disease(CKD)---a Prospective Study

Not Applicable
Conditions
Renal Insufficiency, Chronic
Registration Number
NCT02886975
Lead Sponsor
The Third Xiangya Hospital of Central South University
Brief Summary

The purpose of this study is to determine whether low protein diet and very low protein diet supplemented keto-/amino acid is effective in preventing the progression of chronic kidney disease (CKD , stage 2 to 5).

Detailed Description

Dietary protein restriction represents a basic therapeutic approach in chronic kidney disease(CKD), by reducing the accumulation of nitrogen catabolic substances, and by delaying the progress of CKD and proteinuria, but the effects of the low protein diet on renal failure progression rate remain to be determined.The aim of this study is to evaluate the efficacy of low protein diet and α-keto acid tablet in retard the progress of CKD. This is a prospective study, 100 patients who meet inclusion and exclusion criteria will be included. The changes of glomerular filtration rate in CKD and time to renal replacement will be evaluated after 1 year treatment.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients with chronic kidney disease in stage 2 to 5 (GFR<60 ml/min/1.73m2) receiving conservative treatment for CKD

Exclusion Criteria

None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
changes in glomerular filtration rate1 year

Nutritional status, evaluated by nutrition risk screening (NRS 2002), at the start and during the 1st year of investigators' intervention.

Secondary Outcome Measures
NameTimeMethod
Compliance to diet1 year

Compliance to diet, defined by the participants' persistence in low protein diet, by outpatient follow-up and telephone follow-up.

Nutritional status1 year

Nutritional status, evaluated by nutrition risk screening (NRS 2002), at the start and during the 1st year of investigators' intervention.

Trial Locations

Locations (1)

the Third Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

the Third Xiangya Hospital of Central South University
🇨🇳Changsha, Hunan, China
Min Liu, M.D.
Principal Investigator
Meng Wang, M.M.
Contact
86-731-88618717
znxywm@163.com
Hao Zhang, M.D.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.